Automated insulin delivery (AID) devices are considered the standard of care for people with insulin-requiring diabetes, especially those with type 1 diabetes. Worn on the body, these devices continuously monitor glucose levels and deliver insulin as needed — helping to improve glycemic control, reduce complications, and lower health care costs.

However, Medicaid members — who are disproportionately affected by diabetes — continue to face barriers to accessing AID devices. These include inconsistent coverage policies across states, overly burdensome prior authorization requirements, and limited education for both providers and patients.

This report, developed with support from The Leona M. and Harry B. Helmsley Charitable Trust, explores how Medicaid beneficiaries currently access AID devices and identifies opportunities to expand access to more members living with diabetes.